200 related articles for article (PubMed ID: 28346060)
1. Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder.
Watmuff B; Liu B; Karmacharya R
Pharmacogenomics; 2017 Apr; 18(5):471-479. PubMed ID: 28346060
[TBL] [Abstract][Full Text] [Related]
2. Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.
Watmuff B; Berkovitch SS; Huang JH; Iaconelli J; Toffel S; Karmacharya R
Mol Cell Neurosci; 2016 Jun; 73():96-103. PubMed ID: 26777134
[TBL] [Abstract][Full Text] [Related]
3. Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia.
Liu YN; Lu SY; Yao J
Psychiatry Clin Neurosci; 2017 Sep; 71(9):579-599. PubMed ID: 28393474
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the biology of bipolar disorder using induced pluripotent stem-derived neurons.
Miller ND; Kelsoe JR
Bipolar Disord; 2017 Nov; 19(7):544-551. PubMed ID: 29116664
[TBL] [Abstract][Full Text] [Related]
5. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
[TBL] [Abstract][Full Text] [Related]
6. Using iPSC Models to Understand the Role of Estrogen in Neuron-Glia Interactions in Schizophrenia and Bipolar Disorder.
Reis de Assis D; Szabo A; Requena Osete J; Puppo F; O'Connell KS; A Akkouh I; Hughes T; Frei E; A Andreassen O; Djurovic S
Cells; 2021 Jan; 10(2):. PubMed ID: 33494281
[TBL] [Abstract][Full Text] [Related]
7.
Ishii T; Ishikawa M; Fujimori K; Maeda T; Kushima I; Arioka Y; Mori D; Nakatake Y; Yamagata B; Nio S; Kato TA; Yang N; Wernig M; Kanba S; Mimura M; Ozaki N; Okano H
eNeuro; 2019; 6(5):. PubMed ID: 31540999
[TBL] [Abstract][Full Text] [Related]
8. Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons.
Tamburini C; Li M
Brain Pathol; 2017 Jul; 27(4):508-517. PubMed ID: 28585386
[TBL] [Abstract][Full Text] [Related]
9. Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons.
Engle SJ; Blaha L; Kleiman RJ
Neuron; 2018 Nov; 100(4):783-797. PubMed ID: 30465765
[TBL] [Abstract][Full Text] [Related]
10. Modeling Huntington׳s disease with patient-derived neurons.
Mattis VB; Svendsen CN
Brain Res; 2017 Feb; 1656():76-87. PubMed ID: 26459990
[TBL] [Abstract][Full Text] [Related]
11. Modeling of psychiatric disorders using induced pluripotent stem cell-related technologies.
Nakazawa T; Hashimoto R; Takuma K; Hashimoto H
J Pharmacol Sci; 2019 Aug; 140(4):321-324. PubMed ID: 31257060
[TBL] [Abstract][Full Text] [Related]
12. The use of induced pluripotent stem cells in drug development.
Inoue H; Yamanaka S
Clin Pharmacol Ther; 2011 May; 89(5):655-61. PubMed ID: 21430656
[TBL] [Abstract][Full Text] [Related]
13. Modeling Psychiatric Disorder Biology with Stem Cells.
Das D; Feuer K; Wahbeh M; Avramopoulos D
Curr Psychiatry Rep; 2020 Apr; 22(5):24. PubMed ID: 32318888
[TBL] [Abstract][Full Text] [Related]
14. Neurodevelopmental origins of bipolar disorder: iPSC models.
O'Shea KS; McInnis MG
Mol Cell Neurosci; 2016 Jun; 73():63-83. PubMed ID: 26608002
[TBL] [Abstract][Full Text] [Related]
15. Pluripotent stem cells in neuropsychiatric disorders.
Soliman MA; Aboharb F; Zeltner N; Studer L
Mol Psychiatry; 2017 Sep; 22(9):1241-1249. PubMed ID: 28322279
[TBL] [Abstract][Full Text] [Related]
16. [Bipolar disorder: advances in the prediction of lithium response and development of new therapies using induced pluripotent stem cells].
Santos R; Charnay P
Med Sci (Paris); 2017 Dec; 33(12):1048-1050. PubMed ID: 29261491
[No Abstract] [Full Text] [Related]
17. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
Corti S; Faravelli I; Cardano M; Conti L
Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
[TBL] [Abstract][Full Text] [Related]
18. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.
van Hugte E; Nadif Kasri N
Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501
[TBL] [Abstract][Full Text] [Related]
19. Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models.
Perrottelli A; Marzocchi FF; Caporusso E; Giordano GM; Giuliani L; Melillo A; Pezzella P; Bucci P; Mucci A; Galderisi S
J Psychiatry Neurosci; 2024; 49(2):E109-E125. PubMed ID: 38490647
[TBL] [Abstract][Full Text] [Related]
20. Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities.
Madison JM; Zhou F; Nigam A; Hussain A; Barker DD; Nehme R; van der Ven K; Hsu J; Wolf P; Fleishman M; O'Dushlaine C; Rose S; Chambert K; Lau FH; Ahfeldt T; Rueckert EH; Sheridan SD; Fass DM; Nemesh J; Mullen TE; Daheron L; McCarroll S; Sklar P; Perlis RH; Haggarty SJ
Mol Psychiatry; 2015 Jun; 20(6):703-17. PubMed ID: 25733313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
